Scripta Insights launches GLP-1 Navigator
New member app feature delivers trusted, clinician-backed guidance as millions face GLP-1 access setbacks after CVS Caremark drops Zepbound and WeightWatchers files for bankruptcy.
New member app feature delivers trusted, clinician-backed guidance as millions face GLP-1 access setbacks after CVS Caremark drops Zepbound and WeightWatchers files for bankruptcy.
Lynne Fruth will continue in a part-time role as the president and chairman of the board. Becker will report to the Fruth board of directors and will begin his new role immediately.
The BoxPicker was selected for its comprehensive solution and transformative potential in improving operational efficiency and supporting the evolving role of pharmacists in healthcare delivery.
Customers transferring or filling a new prescription will receive coupon for up to $15 off next grocery purchase of $75 or more.
Pre-travel health consultations also available at select pharmacies.
New law ushers in transparent pharmacy reimbursement for state health plans, fueling momentum for further progress in Georgia and nationwide.
Product will be available for appropriate patients in the second half of 2025.
Agreements provide for the transition of pharmacy assets to CVS Pharmacy, Walgreens, Albertsons, Kroger, and Giant Eagle, among others, and the sale and operation by CVS Pharmacy of many stores in the Pacific Northwest.
Temozolomide Capsules, USP is an alkylating drug.
By Allison Raplee, media director at Greater Than One, a healthcare media, marketing and technology agency
Through Camber’s copayment program, eligible patients may pay as little as $0 out-of-pocket. Visit Camber’s eltrombopag web page for full offer details.
He joins NPC’s team where he will apply his deep knowledge of the research and evidence used to support federal health policymaking to drive NPC’s policy-
Long-overdue Medicaid PBM reforms would protect American taxpayers, patients, pharmacies.
May campaign highlights NACDS members’ support of Nourish My Health.
Aetna invests to improve access to home health care and support the direct care workforce.
In one of the largest and longest real-world obesity studies to date, Embla tracked nearly 2,700 adults over 64 weeks and achieved 16.7% average weight loss using 66% less semaglutide than typical U.S. doses.